How did Erbiquiti's revenue and expenses trend in Q2 2025?

Reckitt Benckiser Group PLC (Reckitt) saw a modest start to 2025 with a 1.1% like-for-like net revenue growth in Q1, primarily driven by strong performance in emerging markets like China and India. However, specific Q2 2025 revenue and expense data is not available. For Q2 2025, Reckitt anticipated low single-digit growth in Europe and mid to high single-digit growth in emerging markets, with North America potentially seeing a low single-digit decline.

Celestica Inc. reported robust performance in Q1 2025, with revenue of $2.65 billion, a 20% increase from the previous year's $2.21 billion. GAAP earnings from operations were 4.9% of revenue, and adjusted operating margin was 7.1%. No specific Q2 2025 data is available for Celestica.

Ebiquity plc had a challenging year in 2024, with a decline in revenue and profitability in the first half, but a stronger performance in the second half, driven by cost controls and strategic initiatives. No specific revenue or expense data for Q2 2025 is available for Ebiquity.

Pure Cycle Corporation reported positive net income for the twenty-third consecutive fiscal quarter as of February 28, 2025. Revenue for the three and six months ended February 28, 2025, was $4.0 million and $9.7 million, respectively, driving pre-tax income of $1.1 million and $6.3 million.

WD-40 Company achieved a 5% increase in net sales in Q2 FY25, reaching $146.1 million, with a gross margin of 54.6% and an operating income of $23.3 million. Currency impacts negatively affected net sales by approximately $4.9 million. Excluding currency impacts, net sales would have increased by 9% compared to the prior year fiscal quarter.

Knowles Corporation reported Q1 2025 revenue at the high end of guidance, with EPS at the midpoint of the guided range. Minimal tariff exposure impacted less than 5% of revenue directly and 3% of the cost of goods sold indirectly, on a non-GAAP basis in Q1 2025.

ASGN Incorporated had revenues of $1.0 billion and net income of $20.9 million in Q1 2025. Adjusted EBITDA was $93.6 million, and the company repurchased 0.6 million shares of common stock for $50.4 million.

Bristol-Myers Squibb Company reported stronger-than-expected financial results for Q1 2025, with EPS of $1.80, surpassing analysts’ forecasts of $1.52. Revenue reached $11.2 billion, exceeding the anticipated $10.68 billion.

Southwest Airlines Co. reported a net loss of $149 million for Q1 2025, with a record first quarter operating revenue of $6.4 billion.

Nexity saw sales momentum in Q1 2025, with reservations up 5%. Revenue under IFRS for Q1 2025 was approximately €590 million, with services up 16%.

Raymond James reported Q2 revenue of $3,400 million, slightly below the IBES estimate of $3,424 million. Adjusted net income was $507 million, with EPS of $2.36 and a ROCE of 18.4%.

In conclusion, specific Q2 2025 revenue and expense data is not available for all companies. However, trends suggest growth in several key financial metrics, with notable performances driven by strategic initiatives and market conditions.